These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6023686)

  • 1. Treatment of urinary bilharziasis in a small focus with sodium antimony dimercaptosuccinate (astiban).
    Arfaa F; Tohidi E; Ardelan A
    Am J Trop Med Hyg; 1967 May; 16(3):300-3. PubMed ID: 6023686
    [No Abstract]   [Full Text] [Related]  

  • 2. Astiban therapy of urinary schistosomiasis: a quantitative evaluation.
    Farid Z; Bassily S; Schulert A; McConnell E
    Ann Trop Med Parasitol; 1966 Jun; 60(2):165-8. PubMed ID: 5962469
    [No Abstract]   [Full Text] [Related]  

  • 3. Suppressive management of urinary schistosomiasis with antimony dimercaptosuccinate (TWSb) in Ghana.
    Wolfe MS; Quansah FO; Agbemadzo F
    J Trop Med Hyg; 1966 Oct; 69(10):217-23. PubMed ID: 5929012
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of schistosomiasis in cardiac patients by weekly injections of sodium antimony dimercaptosuccinate.
    Badran AM; Abdalla A
    J Egypt Med Assoc; 1967; 50(6):360-8. PubMed ID: 5592864
    [No Abstract]   [Full Text] [Related]  

  • 5. Pulmonary function in patients with early asymptomatic schistosomiasis before and after treatment with sodium antimony dimercaptosuccinate (Astiban).
    Fuleihan FJ; Abboud RT
    Am J Trop Med Hyg; 1968 May; 17(3):372-7. PubMed ID: 5652697
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapeutic use of antimony and sodium dimercaptosuccinate in the treatment of schistosomiasis mansoni].
    Teixeira D; de Gouveia OF; Miyahira AR; Galper E; da Cunha MA
    Hospital (Rio J); 1965 Dec; 68(6):1361-75. PubMed ID: 5296034
    [No Abstract]   [Full Text] [Related]  

  • 7. Symptomatic, radiological, and functional improvement following treatment of urinary schistosomiasis in Egypt.
    Farid Z; Bassily S; McConnell E; Schulert A; Sabour M; Abdel Wahab MF
    Lancet; 1967 Nov; 2(7526):1110-3. PubMed ID: 4168554
    [No Abstract]   [Full Text] [Related]  

  • 8. [Bilharziasis in Guadeloupe. Accelerated treatment in the hospital].
    L'Etang E
    J Med Bord; 1965 Jun; 142(6):1049-60. PubMed ID: 5839531
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapeutic evaluation of antimony and sodium dimercaptosuccinate in the treatment of schistosomiasis mansoni].
    Siqueira MW; Huggins D
    Rev Bras Med; 1967 Feb; 24(2):97-9. PubMed ID: 5604907
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of Schistosoma haematobium infection with astiban in Iraqis.
    Awkati A
    Trans R Soc Trop Med Hyg; 1969; 63(5):576-8. PubMed ID: 5824278
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of urinary bilharziasis with antimony dimercaptosuccinate (TWSb).
    ALVES W
    Cent Afr J Med; 1958 Jan; 4(1):15. PubMed ID: 13511426
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapeutic use of dimercaptosuccinate of antimony and sodium (Astiban) in the treatment of Manson's schistosomiasis].
    Teixeira D; de Gouveia OF; Miyahira AR; Galper E; da Cunha MA
    Hospital (Rio J); 1965 Dec; 68(6):1361-75. PubMed ID: 5295283
    [No Abstract]   [Full Text] [Related]  

  • 13. Oral tracer sodium antimony-2, 3-meso-dimercapto-succinate (Astiban) in hamsters infected with Schistosoma mansoni.
    Girgis GR; Girgis NI; Schulert AR; McConnell E
    J Egypt Public Health Assoc; 1966; 41(4):237-42. PubMed ID: 6002838
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of urinary bilharziosis due to Schistosoma haematobium by antimony dimercaptosuccinate].
    FRIEDHEIM EA
    Bull Soc Pathol Exot Filiales; 1956; 49(6):1247-52. PubMed ID: 13426747
    [No Abstract]   [Full Text] [Related]  

  • 15. Suppressive therapy with MsbE and Astiban in hamsters infected with Schistosoma mansoni.
    Baldewsing R
    Trop Geogr Med; 1973 Jun; 25(2):174-8. PubMed ID: 4736841
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of treatment with different antibilharzial drugs on renal functions in urinary schistosomiasis.
    el-Zayadi AM; Shoeb SM; Sabour MS; Basmy K
    Tropenmed Parasitol; 1974 Jun; 25(2):147-52. PubMed ID: 4418544
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of schistosomiasis, past & present. II. Clinical investigations on the treatment of urinary and intestinal bilharziasis with TWSb (antimonv dimercaptosuccinate) with a critical study of its toxic side effects.
    NAGATY HF; RIFAAT MA
    J Egypt Med Assoc; 1960; 43():678-95. PubMed ID: 13727430
    [No Abstract]   [Full Text] [Related]  

  • 18. Astiban therapy of Schistosoma mansoni infection: a quantitative evaluation.
    Farid Z; Bassily S; McConnell E; Davis J
    Ann Trop Med Parasitol; 1967 Sep; 61(3):310-4. PubMed ID: 5625700
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative trials of antimonial drugs in urinary schistosomiasis.
    Davis A
    Bull World Health Organ; 1968; 38(2):197-227. PubMed ID: 5302298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative antimony disposition following administration of tartar emetic and sodium antimony dimercaptosuccinate (Astiban) to hamsters infected with Schistosoma mansoni.
    Schulert AR; Girgis NI; Girgis GR; Farid Z; McConnell E
    East Afr Med J; 1967 Jan; 44(1):1-8. PubMed ID: 6038793
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.